Document is current

Any future updates will be listed below

Anti-tumor necrosis factor patent expiration and the risks of biocopies in clinical practice

Crossref DOI link: https://doi.org/10.1186/s13075-014-0501-5

Published Online: 2014-12-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark